167 related articles for article (PubMed ID: 34494331)
21. The Gene Expression Profile of Uropathogenic Escherichia coli in Women with Uncomplicated Urinary Tract Infections Is Recapitulated in the Mouse Model.
Frick-Cheng AE; Sintsova A; Smith SN; Krauthammer M; Eaton KA; Mobley HLT
mBio; 2020 Aug; 11(4):. PubMed ID: 32788379
[TBL] [Abstract][Full Text] [Related]
22. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
[TBL] [Abstract][Full Text] [Related]
23. Hemolysin of uropathogenic Escherichia coli: A cloak or a dagger?
Ristow LC; Welch RA
Biochim Biophys Acta; 2016 Mar; 1858(3):538-45. PubMed ID: 26299820
[TBL] [Abstract][Full Text] [Related]
24. Cross Talk between MarR-Like Transcription Factors Coordinates the Regulation of Motility in Uropathogenic Escherichia coli.
Luterbach CL; Mobley HLT
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30275009
[TBL] [Abstract][Full Text] [Related]
25. Activation of the NLRP3 Inflammasome Pathway by Uropathogenic
Demirel I; Persson A; Brauner A; Särndahl E; Kruse R; Persson K
Front Cell Infect Microbiol; 2018; 8():81. PubMed ID: 29662840
[TBL] [Abstract][Full Text] [Related]
26. Peptidoglycan endopeptidase MepM of uropathogenic Escherichia coli contributes to competitive fitness during urinary tract infections.
Huang WC; Dwija IBNP; Hashimoto M; Wu JJ; Wang MC; Kao CY; Lin WH; Wang S; Teng CH
BMC Microbiol; 2024 May; 24(1):190. PubMed ID: 38816687
[TBL] [Abstract][Full Text] [Related]
27. Quantification of bacteriuria caused by Hemolysin-positive Escherichia coli in human and mouse urine using quantitative polymerase chain reaction (qPCR) targeting hlyD.
Chamoun MN; Sullivan MJ; Ulett GC
J Microbiol Methods; 2018 Sep; 152():173-178. PubMed ID: 30110601
[TBL] [Abstract][Full Text] [Related]
28. Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli.
Hozzari A; Behzadi P; Kerishchi Khiabani P; Sholeh M; Sabokroo N
J Appl Genet; 2020 May; 61(2):265-273. PubMed ID: 31950434
[TBL] [Abstract][Full Text] [Related]
29. Uropathogenic Escherichia coli Virulence Factor α-Hemolysin Reduces Histone Acetylation to Inhibit Expression of Proinflammatory Cytokine Genes.
Zhang Z; Wang M; Zhang Y; Zhang Y; Bartkuhn M; Markmann M; Hossain H; Chakraborty T; Hake SB; Jia Z; Meinhardt A; Bhushan S
J Infect Dis; 2021 Mar; 223(6):1040-1051. PubMed ID: 33453118
[TBL] [Abstract][Full Text] [Related]
30. Transcriptomic analysis reveals that the small protein MgtS contributes to the virulence of uropathogenic Escherichia coli.
Li S; Pang Y; Zhang S; Li Q; Wang Q; Wang L; Feng L
Microb Pathog; 2021 Mar; 152():104765. PubMed ID: 33524567
[TBL] [Abstract][Full Text] [Related]
31. MOLECULAR CHARACTERIZATION OF VIRULENCE AND ANTIMICROBIAL SUSCEPTIBILITY PROFILES OF UROPATHOGENIC ESCHERICHIA COLI FROM PATIENTS IN A TERTIARY HOSPITAL, SOUTHERN THAILAND.
Themphachanal M; Kongpheng S; Rattanachuay P; Khianngam S; Singkhamanan K; Sukhumungoon P
Southeast Asian J Trop Med Public Health; 2015 Nov; 46(6):1021-30. PubMed ID: 26867360
[TBL] [Abstract][Full Text] [Related]
32. Virulence and Fitness Determinants of Uropathogenic Escherichia coli.
Subashchandrabose S; Mobley HLT
Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350328
[TBL] [Abstract][Full Text] [Related]
33. PafR, a novel transcription regulator, is important for pathogenesis in uropathogenic Escherichia coli.
Baum M; Watad M; Smith SN; Alteri CJ; Gordon N; Rosenshine I; Mobley HL; Amster-Choder O
Infect Immun; 2014 Oct; 82(10):4241-52. PubMed ID: 25069986
[TBL] [Abstract][Full Text] [Related]
34. Roles of OmpX, an Outer Membrane Protein, on Virulence and Flagellar Expression in Uropathogenic Escherichia coli.
Hirakawa H; Suzue K; Takita A; Kamitani W; Tomita H
Infect Immun; 2021 May; 89(6):. PubMed ID: 33753414
[TBL] [Abstract][Full Text] [Related]
35. Molecular Characterization of the Vacuolating Autotransporter Toxin in Uropathogenic Escherichia coli.
Nichols KB; Totsika M; Moriel DG; Lo AW; Yang J; Wurpel DJ; Rossiter AE; Strugnell RA; Henderson IR; Ulett GC; Beatson SA; Schembri MA
J Bacteriol; 2016 May; 198(10):1487-98. PubMed ID: 26858103
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells.
Gur C; Coppenhagen-Glazer S; Rosenberg S; Yamin R; Enk J; Glasner A; Bar-On Y; Fleissig O; Naor R; Abed J; Mevorach D; Granot Z; Bachrach G; Mandelboim O
Cell Host Microbe; 2013 Dec; 14(6):664-74. PubMed ID: 24331464
[TBL] [Abstract][Full Text] [Related]
37. The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia.
Vigil PD; Wiles TJ; Engstrom MD; Prasov L; Mulvey MA; Mobley HL
Infect Immun; 2012 Feb; 80(2):493-505. PubMed ID: 22083710
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections.
Dbeibo L; van Rensburg JJ; Smith SN; Fortney KR; Gangaiah D; Gao H; Marzoa J; Liu Y; Mobley HLT; Spinola SM
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29311237
[TBL] [Abstract][Full Text] [Related]
39. Flexible Metabolism and Suppression of Latent Enzymes Are Important for
Alteri CJ; Himpsl SD; Shea AE; Mobley HLT
J Bacteriol; 2019 Aug; 201(16):. PubMed ID: 31160397
[TBL] [Abstract][Full Text] [Related]
40. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance.
Shah C; Baral R; Bartaula B; Shrestha LB
BMC Microbiol; 2019 Sep; 19(1):204. PubMed ID: 31477018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
